Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, April 30, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Humana’s acquisition of the remaining stake in Kindred at Home, valued at $5.7 billion, including debt, from TPG Capital and Welsh, Carson, Anderson & Stowe. The three companies bought Kindred together in 2017 deal valued at $4.1 billion. Including Humana’s initial investment in 2017, the company has paid $7.1... Read More »
Molina Healthcare Expands in Texas
The Managed Care-giant Molina Health, Inc. (NYSE: MOH) has announced a deal with Cigna (NYSE: CI). Molina is purchasing Cigna’s Texas Medicaid and Medicare-Medicaid Plans (MMP) for $60 million. As of December 31, 2020, Cigna’s Texas MMP business served approximately 48,000 Medicaid members in the STAR+PLUS program in the Hidalgo, Tarrant, and Northeast service areas, and approximately 2,000 MMP members in the Hidalgo service area. In 2020, the business generated a premium revenue of approximately $1.0 billion. This transaction is a huge boost into the Texas Medicaid and Medicare market, another step in Molina’s path for growth. Throughout 2020, the company announced a string of... Read More »
KNR Therapy Grows Florida Footprint
Activity in the Behavioral Health Care sector surged in the first quarter of 2021, rising 76% in deal volume compared with the fourth quarter of 2020 and 85% compared with activity in Q1:20, according to search results in our Healthcare Deals Database. Much of that demand came from the unfortunate mental health stress caused by the Covid-19 pandemic, and even with a “return-to-normal life” on the horizon, that demand doesn’t seem to be subsiding. However, it’s not just counseling and clinical services; other specialties such as autism treatment services are highly sought after. Even with all that activity, there is still room for new players to enter the M&A market, looking... Read More »
Health Care M&A Deals, April 23, 2021
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Accolade, Inc.’s acquisition of PlushCare, a leading virtual primary care and mental health platform that offers virtual doctor visits to patients in all 50 U.S. states. The deal was valued at $390 million, consisting of $40 million in cash and $340 million in Accolade common stock. Additionally, Accolade will pay up to an additional $70... Read More »
And the Audience Says…
Last week, we hosted a webinar tackling the differences between two classes of seniors housing communities: “A” quality versus “B” quality. Often, buyers and investors of one group do not do much business in the other, so it is worth breaking out the differences in valuation, operations and investment strategies. So, for the last several years in our annual Senior Care Acquisition Report, we have divided seniors housing properties into these categories based on a combination of their age, size and location. Leading up to the pandemic, prices paid for “A” quality properties were surging as labor and occupancy headwinds seemed to be affecting “B” (and “C”)... Read More »
Accolade Acquires Telehealth Platform PlushCare
Telehealth demand is still going strong. Accolade, Inc. (NASDAQ: ACCD), a Seattle-based digital health company, has announced the acquisition of PlushCare, a leading virtual primary care and mental health platform that offers virtual doctor visits to patients in all 50 U.S. states. The deal was valued at $390 million, consisting of $40 million in cash and $340 million in Accolade common stock. Additionally, Accolade will pay up to an additional $70 million payable upon the achievement of defined revenue milestones. In 2020, PlushCare generated $35 million in unaudited revenues. In the news release, Accolade stated that it expects the acquisition will be accretive to its growth rate and... Read More »
Health Care M&A Deals, April 16, 2021
[et_pb_text admin_label=”Text”] The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Thermo Fisher Scientific Inc.’s acquisition of PPD, Inc. for $20.9 billion, consisting of a payment of $17.4 billion and the assumption of $3.4 billion in net debt. PPD is a leading CRO providing broad, integrated drug development, laboratory and lifecycle management services. Its customers include... Read More »
Thermo Fisher Bets $20 Billion on Leading CRO
The laboratory and diagnostics giant Thermo Fisher Scientific Inc. (NYSE: TMO) announced a huge deal for an international contract research organization (CRO) last week. Thermo Fisher is buying PPD, Inc. (NASDAQ: PPD), a leading CRO providing broad, integrated drug development, laboratory and lifecycle management services. Its customers include pharmaceutical, biotechnology, medical device, academic and government organizations. The company has offices in 47 countries and more than 26,000 employees. Its headquarters is based in Wilmington, North Carolina. Thermo Fisher is offering $17.4 billion for PPD, or $47.50 per share for the company, a premium of approximately... Read More »
